During the past decade, Krakowska Akademia Neurologii Sp. z o. o. conducted 29 clinical trials. In the 10-year time frame, 29 clinical trials started and 15 clinical trials were completed, i.e. on average, 51.7% percent of trials that started reached the finish line to date. In the past 5 years, 13 clinical trials started and 8 clinical trials were completed. i.e. 61.5% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Krakowska Akademia Neurologii Sp. z o. o." #1 sponsor was "Hoffmann-La Roche" with 6 trials, followed by "Ipsen" with 4 trials sponsored, "ACADIA Pharmaceuticals Inc." with 2 trials sponsored, "AstraZeneca" with 2 trials sponsored and "Celgene" with 2 trials sponsored. Other sponsors include 21 different institutions and companies that sponsored additional 23 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Krakowska Akademia Neurologii Sp. z o. o." #1 collaborator was "Eli Lilly and Company" with 2 trials as a collaborator, "Syneos Health" with 2 trials as a collaborator, "Bayer" with 1 trials as a collaborator, "Chugai Pharmaceutical" with 1 trials as a collaborator and "Prothena Biosciences Limited" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 6 trials.

According to Clinical.Site data, the most researched conditions in "Krakowska Akademia Neurologii Sp. z o. o." are "Parkinson's Disease" (5 trials), "Relapsing Multiple Sclerosis" (3 trials), "Agitation in Patients With Dementia of the Alzheimer's Type" (2 trials), "Alzheimer's Disease" (2 trials) and "Cervical Dystonia" (2 trials). Many other conditions were trialed in "Krakowska Akademia Neurologii Sp. z o. o." in a lesser frequency.

Most popular intervention types in "Krakowska Akademia Neurologii Sp. z o. o." are "Drug" (36 trials), "Biological" (8 trials), "Other" (2 trials) and "Combination Product" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (23 trials), "Botulinum toxin type A" (4 trials), "Interferon beta-1a" (3 trials), "AVP-786" (2 trials) and "Accordion Pill™ Carbidopa/Levodopa" (2 trials). Other intervention names were less common.

The vast majority of trials in "Krakowska Akademia Neurologii Sp. z o. o." are 42 trials for "All" genders.

Currently, there are NaN active trials in "Krakowska Akademia Neurologii Sp. z o. o.". undefined are not yet recruiting, 8 are recruiting, 4 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 23 completed trials in Krakowska Akademia Neurologii Sp. z o. o., undefined suspended trials, and 5 terminated clinical trials to date.

Out of the total trials that were conducted in Krakowska Akademia Neurologii Sp. z o. o., 0 "Phase 1" clinical trials were conducted, 13 "Phase 2" clinical trials and 30 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".

Krakowska Akademia Neurologii Sp. z o. o. has several departments that took part in Clinical trials: "Krakowska Akademia Neurologii Sp. z o.o." - 2 trials